TA
LLY icon

TFB Advisors’s Eli Lilly LLY Stock Holding History

TFB Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$979K Sell
816
-3
-0.4% -$3.06K 0.43% 57
2026
Q1 		$753K Sell
819
-169
-17% -$171K 0.39% 58
2025
Q4 		$1.06M Sell
988
-10
-1% -$9.56K 0.3% 78
2025
Q3 		$811K Sell
998
-673
-40% -$501K 0.24% 106
2025
Q2 		$1.3M Sell
1,671
-86
-5% -$66.8K 0.34% 70
2025
Q1 		$1.45M Buy
1,757
+52
+3% +$43.3K 0.42% 55
2024
Q4 		$1.32M Sell
1,705
-272
-14% -$225K 0.38% 58
2024
Q3 		$1.75M Buy
1,977
+46
+2% +$41.4K 0.52% 41
2024
Q2 		$1.75M Buy
1,931
+187
+11% +$150K 0.57% 39
2024
Q1 		$1.35M Buy
1,744
+844
+94% +$601K 0.49% 49
2023
Q4 		$525K Buy
+900
New +$525K 0.27% 85
2023
Q3 		– Sell
-914
Closed -$429K – 175
2023
Q2 		$429K Buy
914
+110
+14% +$46.1K 0.19% 129
2023
Q1 		$276K Buy
804
+44
+6% +$14.8K 0.21% 102
2022
Q4 		$278K Buy
+760
New +$269K 0.23% 92

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TFB Advisors's LLY Position: Q2 2026 in Review

TFB Advisors reduced its Eli Lilly (LLY) stake by 0.37% in Q2 2026, selling an estimated $3.06K and leaving 816 shares worth $979K. The position accounts for 0.43% of the portfolio, ranked #57.

TFB Advisors first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.75M in Q3 2024. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • TFB Advisors held 816 shares of Eli Lilly worth $979K as of Q2 2026.
  • TFB Advisors sold 3 Eli Lilly shares in Q2 2026, an estimated $3.06K.
  • Eli Lilly made up 0.43% of TFB Advisors's portfolio in Q2 2026, its #57 holding.
  • TFB Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • TFB Advisors's Eli Lilly position peaked at $1.75M in Q3 2024.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on TFB Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.